|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng S, Lv P, Su J, Miao K, Xu H and Li
M: Silencing of the long non-coding RNA RHPN1-AS1 suppresses the
epithelial-to-mesenchymal transition and inhibits breast cancer
progression. Am J Transl Res. 11:3505–3517. 2019.PubMed/NCBI
|
|
3
|
Dong Y, Wang ZG and Chi TS: Long noncoding
RNA Lnc01614 promotes the occurrence and development of gastric
cancer by activating EMT pathway. Eur Rev Med Pharmacol Sci.
22:1307–1314. 2018.PubMed/NCBI
|
|
4
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hirano T, Yoshikawa R, Harada H, Harada Y,
Ishida A and Yamazaki T: Long noncoding RNA, CCDC26, controls
myeloid leukemia cell growth through regulation of KIT expression.
Mol Cancer. 14:902015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prensner JR, Iyer MK, Balbin OA,
Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso
CS, Kominsky HD, et al: Transcriptome sequencing across a prostate
cancer cohort identifies PCAT-1, an unannotated lincRNA implicated
in disease progression. Nat Biotechnol. 29:742–749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tordonato C, Di Fiore PP and Nicassio F:
The role of non-coding RNAs in the regulation of stem cells and
progenitors in the normal mammary gland and in breast tumors. Front
Genet. 6:722015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin XC, Zhu Y, Chen WB, Lin LW, Chen DH,
Huang JR, Pan K, Lin Y, Wu BT, Dai Y and Tu ZG: Integrated analysis
of long non-coding RNAs and mRNA expression profiles reveals the
potential role of lncRNAs in gastric cancer pathogenesis. Int J
Oncol. 45:619–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cao WJ, Wu HL, He BS, Zhang YS and Zhang
ZY: Analysis of long non-coding RNA expression profiles in gastric
cancer. World J Gastroenterol. 19:3658–3664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu D, Zhang MY, Chu Z and Zhang M: Long
non-coding RNA HOST2 enhances proliferation and metastasis in
gastric cancer. Neoplasma. 66:101–108. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pan L, Liang W, Gu J, Zang X, Huang Z, Shi
H, Chen J, Fu M, Zhang P, Xiao X, et al: Long noncoding RNA DANCR
is activated by SALL4 and promotes the proliferation and invasion
of gastric cancer cells. Oncotarget. 9:1915–1930. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rezanejad Bardaji H, Asadi MH and Yaghoobi
MM: Long noncoding RNA VIM-AS1 promotes colorectal cancer
progression and metastasis by inducing EMT. Eur J Cell Biol.
97:279–288. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao X, Jiang X, Liu Z, Zhou M, Zhang J,
Wang X and Li X: Long noncoding RNA VIM antisense RNA 1 (VIM-AS1)
plays an important role in development of preeclampsia by
regulation of epithelial mesenchymal transition. Med Sci Monit.
25:8306–8314. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu
XY, Yu ZW, Jia YH, Bai XF, Li L, et al: The lncRNA CRNDE promotes
colorectal cancer cell proliferation and chemoresistance via
miR-181a-5p-mediated regulation of Wnt/beta-catenin signaling. Mol
Cancer. 16:92017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng C, Li X, Yu Y and Chen J: LncRNA
GASL1 inhibits tumor growth in gastric carcinoma by inactivating
the Wnt/β-catenin signaling pathway. Exp Ther Med. 17:4039–4045.
2019.PubMed/NCBI
|
|
17
|
Wang Y, Xiao S, Wang B, Li Y and Chen Q:
Knockdown of lncRNA TP73-AS1 inhibits gastric cancer cell
proliferation and invasion via the WNT/β-catenin signaling pathway.
Oncol Lett. 16:3248–3254. 2018.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang L, Wu RL and Xu AM:
Epithelial-mesenchymal transition in gastric cancer. Am J Transl
Res. 7:2141–2158. 2015.PubMed/NCBI
|
|
20
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Renganathan A and Felley-Bosco E: Long
noncoding RNAs in cancer and therapeutic potential. Adv Exp Med
Biol. 1008:199–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He C, Yang W and Yang J, Ding J, Li S, Wu
H, Zhou F, Jiang Y, Teng L and Yang J: Long noncoding RNA MEG3
negatively regulates proliferation and angiogenesis in vascular
endothelial cells. DNA Cell Biol. 36:475–481. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu T, Liu Y, Wei C, Yang Z, Chang W and
Zhang X: LncRNA HULC promotes the progression of gastric cancer by
regulating miR-9-5p/MYH9 axis. Biomed Pharmacother. 121:1096072019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qu CX, Shi XC, Bi H, Zhai LQ and Yang Q:
LncRNA AOC4P affects biological behavior of gastric cancer cells
through MAPK signaling pathway. Eur Rev Med Pharmacol Sci.
23:8852–8860. 2019.PubMed/NCBI
|
|
26
|
Wang MW, Liu J, Liu Q, Xu QH, Li TF, Jin S
and Xia TS: LncRNA SNHG7 promotes the proliferation and inhibits
apoptosis of gastric cancer cells by repressing the P15 and P16
expression. Eur Rev Med Pharmacol Sci. 21:4613–4622.
2017.PubMed/NCBI
|
|
27
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer-trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Flahaut M, Meier R, Coulon A, Nardou KA,
Niggli FK, Martinet D, Beckmann JS, Joseph JM, Mühlethaler-Mottet A
and Gross N: The Wnt receptor FZD1 mediates chemoresistance in
neuroblastoma through activation of the Wnt/beta-catenin pathway.
Oncogene. 28:2245–2256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang H, Zhang X, Wu X, Li W, Su P, Cheng
H, Xiang L, Gao P and Zhou G: Interference of Frizzled 1 (FZD1)
reverses multidrug resistance in breast cancer cells through the
Wnt/β-catenin pathway. Cancer Lett. 323:106–113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Milovanovic T, Planutis K, Nguyen A, Marsh
JL, Lin F, Hope C and Holcombe RF: Expression of Wnt genes and
frizzled 1 and 2 receptors in normal breast epithelium and
infiltrating breast carcinoma. Int J Oncol. 25:1337–1342.
2004.PubMed/NCBI
|
|
33
|
Merle P, Kim M, Herrmann M, Gupte A,
Lefrançois L, Califano S, Trépo C, Tanaka S, Vitvitski L, de la
Monte S and Wands JR: Oncogenic role of the frizzled-7/beta-catenin
pathway in hepatocellular carcinoma. J Hepatol. 43:854–862. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ara H, Takagishi M, Enomoto A, Asai M,
Ushida K, Asai N, Shimoyama Y, Kaibuchi K, Kodera Y and Takahashi
M: Role for Daple in non-canonical Wnt signaling during gastric
cancer invasion and metastasis. Cancer Sci. 107:133–139. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Karimaian A, Majidinia M, Bannazadeh Baghi
H and Yousefi B: The crosstalk between Wnt/β-catenin signaling
pathway with DNA damage response and oxidative stress: Implications
in cancer therapy. DNA Repair (Amst). 51:14–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shan Y, Ying R, Jia Z, Kong W, Wu Y, Zheng
S and Jin H: LINC00052 promotes gastric cancer cell proliferation
and metastasis via activating the Wnt/β-catenin signaling pathway.
Oncol Res. 25:1589–1599. 2017. View Article : Google Scholar : PubMed/NCBI
|
